Recurrent Ovarian Cancer - Globe Thesis

Keyword [Recurrent Ovarian Cancer] Result: 21 - 40 \| Page: 2 of 4
21.	Analysis Of Factors Influencing The Secondary Surgical Treatment Of Recurrent Ovarian Cancer
22.	Efficacy In The Treatment Of Recurrent Ovarian Cancer Of Different Drug Combination Nedaplatin
23.	Bevacizumab For Recurrent Ovarian Cancer:a Systematic Review And Clinical Analysis Of57Cases
24.	Impact Of Dose-dense Administration Of Cisplatin And Paclitaxel On The Repopulation Of Skov3Cells And Its Effect On Recurrent Ovarian Cancer Patients With Platinum-resistance
25.	Evaluation Of Quality Of Life Of Different Treatment For Recurrent Ovarian Cancer Patients
26.	The Efficacy And Safety Of Bevacizumab In Combination With Chemotherapy For Treatment Of Recurrent Epithelial Ovarian Cancer:a Systematic Review
27.	Clinical Efficacy Of Cellular Immunotherapy Combined With Chemotherapy For Treatment Of Recurrent Ovarian Cancer
28.	Clinical Observation Of Different Chemotherapy Regimens For Patients With Recurrent Ovarian Cance
29.	Impact Of Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography On Diagnostic Value And Patient Management In The Suspected Recurrent Ovarian Cancer:a Meta-analysis
30.	Analyze The Influential Factors Of Disease-free Interval And The Prognosis After Treatment In 56 Patients With Recurrent Ovarian Cancer
31.	The Clinical Observation Of Hyperthermic Intraperitoneal Chemotherapy Combined With Intravenous Chemotherapy In The Treatment Of Recurrent Ovarian Cancer
32.	Analysis Of Influential Factors Of Recurrent Ovarian Cancer
33.	Antiangiogenic Drugs Used With Chemotheropy For Patients With Recurrent Ovarian Cancer:a Meta-analysis
34.	A Systematic Review Of The Secondary Cytoreductive Surgery In Platinum-sensitive Ecurrent Ovarian Cancer
35.	MiR-9 And MiR-210 In Drug-resistant Recurrent Ovarian Cancer Cells:Expression,Function And Its Mechanism
36.	Treatment Of Recurrent Ovarian Cancer With Intravenous Chemotherapy And Intraperitoneal Heat Perfusion Chemotherapy
37.	1 Nedaplatin And Paclitaxel Compared With Carboplatin And Paclitaxel For Patients With Platinum-Sensitive Recurrent Ovarian Cancer 2 Copy Number Variations Of Neurotrophic Tyrosine Receptor Kinase 3 (NTRK3) May Predict Prognosis Of Ovarian Cancer
38.	Advances In Gene And Immunology Therapy Of Recurrent Ovarian Cancer
39.	The Latest Progress Of Oral Targeted Drug—PAPRi In Epithelial Recurrent Ovarian Cancer
40.	Evaluation Of Short-term Curative Effect Of Apatinib Mesylate On Recurrent Epithelial Ovarian Cancer
<<First <Prev Next> Last>> Jump to